NexImmune, Inc.
NEXIDelisted Sep 6, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001538210
NexImmune, Inc. was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 13 institutions reported holding it in 13F filings for Q2 2024, worth $408.6K in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding NexImmune, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 32 | 31 | −1 |
| Shares | 4.45M | 4.40M | −58.3K (−1.3%) |
| Value | $1.26M | $921.4K | −$333.9K (−26.6%) |
New holders (3)
Institutions that held NexImmune, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Comerica Bank | 81,421 | $17.1K | 0.00% |
| Morgan Stanley | 446 | $94 | 0.00% |
| Qube Research & Technologies Ltd | 4 | $1 | 0.00% |
Sold out (4)
Institutions that held NexImmune, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Envestnet Asset Management Inc | 81,421 | $22.9K |
| Jane Street Group, LLC | 44,969 | $12.7K |
| HRT Financial LP | 41,958 | $11.0K |
| Davenport & Co LLC | 26,000 | $7.33K |